Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Polarityte Inc (PTE)

Polarityte Inc (PTE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,901
  • Shares Outstanding, K 5,633
  • Annual Sales, $ 9,400 K
  • Annual Income, $ -30,190 K
  • 60-Month Beta 1.31
  • Price/Sales 0.41
  • Price/Cash Flow N/A
  • Price/Book 0.15
Trade PTE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.80
  • Most Recent Earnings -1.30 on 08/11/22
  • Next Earnings Date 11/09/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 120.83%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,681.89% on 09/27/22
  • IV Low 0.00% on 09/30/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 946
  • Open Int (30-Day) 946

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.21
  • Number of Estimates 1
  • High Estimate -1.21
  • Low Estimate -1.21
  • Prior Year -2.25
  • Growth Rate Est. (year over year) +46.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6130 +41.92%
on 09/28/22
1.0900 -20.18%
on 09/22/22
-0.1800 (-17.14%)
since 08/30/22
3-Month
0.6130 +41.92%
on 09/28/22
1.9000 -54.21%
on 08/04/22
-0.5800 (-40.00%)
since 06/30/22
52-Week
0.6130 +41.92%
on 09/28/22
20.7500 -95.81%
on 01/18/22
-15.3050 (-94.62%)
since 09/30/21

Most Recent Stories

More News
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business...

PTE : 0.8700 (+27.94%)
PolarityTE, Inc. (PTE) Reports Q1 Loss, Misses Revenue Estimates

PolarityTE, Inc. (PTE) delivered earnings and revenue surprises of -25% and 12.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PTE : 0.8700 (+27.94%)
TARO : 29.98 (+4.31%)
PLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue Estimates

PLx Pharma, Inc. (PLXP) delivered earnings and revenue surprises of 4.35% and 11.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PLXP : 0.6500 (+23.72%)
PTE : 0.8700 (+27.94%)
Altimmune, Inc. (ALT) Reports Q1 Loss, Misses Revenue Estimates

Altimmune, Inc. (ALT) delivered earnings and revenue surprises of 22.81% and 98.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ALT : 12.77 (+1.19%)
PTE : 0.8700 (+27.94%)
PTE Stock Is Rocketing Nearly 100% Today. It’s About Time.

PTE stock surges as optimism rises among penny stock investors

PTE : 0.8700 (+27.94%)
Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today

Microcap biotech stocks are skyrocketing today. Here are the names investors need to know.

SBFM : 0.7725 (+0.32%)
PTE : 0.8700 (+27.94%)
QLGN : 0.2670 (-5.99%)
LIXT : 0.5602 (+2.73%)
ATNM : 7.38 (+2.50%)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

ZSAN and HOTH are leading our lists this morning

PTE : 0.8700 (+27.94%)
AGLE : 0.5260 (+7.37%)
BDSX : 1.2700 (-5.93%)
VERU : 11.52 (-1.71%)
ZSAN : 0.5576 (+7.23%)
MediWound (MDWD) Reports Q4 Loss, Misses Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of 6.25% and 2.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

MDWD : 1.3900 (-0.71%)
PTE : 0.8700 (+27.94%)
PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study

PolarityTE (PTE) announces removal of clinical hold on a proposed pivotal study to evaluate its SkinTE for chronic cutaneous ulcers. PolarityTE plans to start enrollment in the next few months.

SPPI : 0.4300 (-4.44%)
PTE : 0.8700 (+27.94%)
AZYO : 7.20 (+7.46%)
BVS : 7.00 (-0.99%)
POLARITYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating PolarityTE, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PolarityTE, Inc. (NASDAQ: PTE) on behalf of long-term stockholders following...

PTE : 0.8700 (+27.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PolarityTE, Inc. creates regenerative medicine and provides tissue engineering platform. It develops and obtains regulatory approval for technology which utilizes a patient's own tissue substrates for regeneration of skin, bone, muscle, cartilage and nerves. The product pipeline comprises SkinTE, OsteoTE,...

See More

Key Turning Points

3rd Resistance Point 1.1852
2nd Resistance Point 1.0476
1st Resistance Point 0.9588
Last Price 0.8700
1st Support Level 0.7324
2nd Support Level 0.5948
3rd Support Level 0.5060

See More

52-Week High 20.7500
Fibonacci 61.8% 13.0577
Fibonacci 50% 10.6815
Fibonacci 38.2% 8.3053
Last Price 0.8700
52-Week Low 0.6130

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar